A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma
about
A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma
description
scientific article published on 27 November 2019
@en
name
A Phase Ib/II, open-label, mul ...... ts with recurrent glioblastoma
@en
type
label
A Phase Ib/II, open-label, mul ...... ts with recurrent glioblastoma
@en
prefLabel
A Phase Ib/II, open-label, mul ...... ts with recurrent glioblastoma
@en
P2093
P50
P1476
A Phase Ib/II, open-label, mul ...... ts with recurrent glioblastoma
@en
P2093
Analia Azaro
Andrew B Lassman
Hefei Zhang
Jordi Rodon
Juan Sepulveda
Markus Joerger
O Alejandro Balbin
Patrick Y Wen
Ralph Tiedt
Sergio Vicente
P356
10.1007/S11060-019-03337-2
P577
2019-11-27T00:00:00Z